Innovation Funding Database
Choose Your Area of Innovation:
Advanced Materials & Manufacturing
Aerospace & Spacetech
Agtech & Foodtech
Artificial Intelligence & Machines Learning
Biotech
Cleantech & Climatetech
Cybersecurity
Defensetech & Dual-Use Tech
eXtended Reality
Healthtech
Medtech
Other Tech
Quantum & Photonics
Robotics & Autonomous Systems
CDMRP: Lupus Research Program (LRP)
Deadline: TBD
Funding Award Size: $250k - $2m
Description: Apply for FY26 CDMRP Lupus Research Program funding. Awards up to $2M for lupus research, innovation, and quality-of-life studies.
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The CDMRP’s FY26 Lupus Research Program (LRP) pre-announcement signals anticipated funding opportunities supporting innovative, high-impact lupus research aimed at understanding, preventing, diagnosing, and treating lupus, as well as improving the quality of life for individuals living with lupus. This pre-announcement does not include application deadlines or guarantee funding — the official Funding Opportunity Announcements (FOAs) will be posted on Grants.gov with formal deadlines and requirements. Investigators should begin planning now to align with expected FY26 mechanisms and program goals.
How much funding would I receive?
The pre-announcement outlines multiple award mechanisms with specified maximum total costs:
Idea Award – up to $300,000 (2 years)
Impact Award – up to $1,000,000 (4 years)
Transformative Vision Development Award – up to $250,000 (2 years)
Transformative Vision Award – up to $2,000,000 (4 years)
What could I use the funding for?
Funding must support research aligned with one or more LRP focus areas:
Biological & Clinical Research
Mechanisms of lupus disease and pathobiology
Genetic, epigenetic, and gene–environment interaction studies
Disease heterogeneity, presentations, and outcomes
Applies to Idea & Impact Awards
Quality of Life & Intervention Studies
Addressing social determinants of health
Nutrition, symptom control, comparative effectiveness
Outcomes research and patient-reported outcomes
Applies to Impact, Transformative Vision Development, and Transformative Vision Awards
Innovative Health Care Delivery Models
Models improving lupus outcomes
Applies to Impact, Transformative Vision Development, and Transformative Vision Awards
Are there any additional benefits I would receive?
Mechanism clarity ahead of FOAs allows early planning.
Subscribe to email updates through eBRAP for timely notifications when FOAs are released.
Being positioned early can improve competitiveness.
What is the timeline to apply and when would I receive funding?
Pre-announcement released: February 11, 2026.
Formal FOAs — will be posted on Grants.gov with official pre-application and full application deadlines.
Investigators must submit a pre-application through eBRAP prior to the pre-application deadline specified in the FOAs.
Where does this funding come from?
Funding is provided through the FY26 Defense Appropriations Act appropriated to the Congressionally Directed Medical Research Programs (CDMRP) and managed by the Defense Health Agency Research & Development and Medical Research and Development Command (DHA R&D-MRDC).
Who is eligible to apply?
Eligibility is defined by mechanism:
Idea Award: Investigators at or above postdoctoral level.
Impact & Transformative Awards: Investigators at or above Assistant Professor (or equivalent).
Team Requirements: Transformative mechanisms must include at least one lupus consumer advocate as part of the research team.
What companies and projects are likely to win?
Projects that:
Align tightly with the specified focus areas.
Demonstrate high innovation and impact potential.
Involve strong preliminary data (as required for Transformative Vision Award).
Include meaningful involvement of lupus consumer advocates (for transformative mechanisms).
Are there any restrictions I should know about?
This pre-announcement is not a funding commitment; only the FOAs establish requirements and obligations.
Applications cannot support clinical trials in Idea or Impact Awards; Transformative Vision Awards may support clinical trials but not animal studies.
Transformative Vision Development Awards cannot support clinical trials or animal studies.
How long will it take me to prepare an application?
Preparation time depends on mechanism and complexity, but begin planning now — especially for pilot data and consumer engagement for transformative mechanisms. Historically, competitive CDMRP applications often require several weeks to months of focused preparation.
How can BW&CO help?
BW&CO can:
Develop alignment narratives tied to LRP focus areas.
Assist with preliminary data framing and research strategy articulation.
Craft strong consumer advocacy integration plans.
Ensure conformity with CDMRP review criteria once FOAs are released.
How much would BW&CO Charge?
We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.
Additional Resources
Review the solicitation here.
Administration for Community Living (ACL): Caregiver AI Challenge
Deadline: April 15, 2026
Funding Award Size: $100k
Description: Apply to the ACL Caregiver AI Challenge by July 31, 2026. Up to $2.5 million in federal prize funding for AI solutions that support caregivers and the direct care workforce
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The Caregiver AI Challenge is a new federal prize competition launched by the Administration for Community Living (ACL), part of the U.S. Department of Health and Human Services (HHS), to accelerate practical, ethical, and scalable AI technologies that support caregivers—including family, friends, and direct care workers—across the U.S. Caregiving demands are rising dramatically, and this challenge seeks tools that reduce caregiver burden, improve quality of care, and strengthen workforce systems. Phase 1 of the competition is open for applications now, with a Phase 1 deadline of July 31, 2026 for submissions.
How much funding would I receive?
Total Phase 1 funding pool: up to $2.5 million across prizes for winners.
Phase 1 prizes: Up to 10 awards of up to $100,000 each per track.
Additional merit prizes up to $50,000 for targeted focus areas (e.g., dementia support, interoperability, partnerships).
Subsequent phases will have additional prizes (to be announced).
What could I use the funding for?
Caregiver Support Tools (Track 1)
AI technologies that assist home caregivers with daily tasks.
Tools that improve scheduling, monitoring, communication, safety, documentation reduction, or training support.
Workforce Support Tools (Track 2)
AI solutions that help home care employers and networks improve efficiency, task automation, staff scheduling, recruitment/retention, and training systems.
Are there any additional benefits I would receive?
Public recognition and validation of your technology within federal aging/disability networks.
Technical assistance and access to federal and non-federal partners during phases.
Potential momentum toward commercialization, scaling, and follow-on opportunities.
What is the timeline to apply and when would I receive funding?
Phase 1 application deadline: July 31, 2026 (established in press coverage).
Winners for Phase 1 are selected after the application review following that deadline.
Funding is typically paid out after phase awards are announced and eligibility requirements are met.
Where does this funding come from?
This is a federal prize competition administered by the ACL within HHS and conducted under the America COMPETES Act, aimed at catalyzing innovation in caregiving through responsible AI technologies.
Who is eligible to apply?
Individuals, teams, or organizations of any type may apply as long as they comply with competition eligibility.
Applicants must be 18 or older.
U.S. citizens/permanent residents are eligible to win prizes; non-U.S. participants can participate but cannot receive prize awards.
What companies and projects are likely to win?
Likely winners will propose AI solutions that:
Are already at Technology Readiness Level (TRL) ≥ 3 with concrete design and use cases.
Demonstrate strong human-centered design with caregiver input.
Show potential to improve caregiving safety, reduce burden, or extend workforce capabilities.
Align with responsible AI principles (privacy, accountability, transparency, safety).
Are there any restrictions I should know about?
Federal employees/involved parties and federal entities cannot win.
Solutions must directly address caregiver challenges (not tangential AI tech).
Must respect competition responsible AI design principles (e.g., privacy, dignity, user control).
How long will it take me to prepare an application?
Preparation time will vary based on the maturity of your AI tool; typical steps include:
Defining caregiver problems and solution design (expert interviews).
Documenting technology readiness and evidence of impact.
Drafting implementation/testing plans that integrate caregiver/user feedback.
Expect several weeks to months of preparation for a competitive submission.
How can BW&CO help?
BW&CO can:
Translate the competition’s priorities into compelling narrative Q&A (aligned with HHS goals).
Map your technology’s current progress to the Phase 1 judging criteria.
Assist with application drafting to emphasize caregiver impact and responsible AI design.
How much would BW&CO Charge?
We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.
Additional Resources
Review the solicitation here.